- Home
- HFBL vs AKTX Comparison
HFBL vs AKTX Comparison
Compare HFBL & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- AKTX
- Stock Information
- Founded
- HFBL 1924
- AKTX N/A
- Country
- HFBL United States
- AKTX United States
- Employees
- HFBL N/A
- AKTX N/A
- Industry
- HFBL Savings Institutions
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- AKTX Health Care
- Exchange
- HFBL Nasdaq
- AKTX Nasdaq
- Market Cap
- HFBL 39.4M
- AKTX 34.7M
- IPO Year
- HFBL N/A
- AKTX N/A
- Fundamental
- Price
- HFBL $12.82
- AKTX $1.28
- Analyst Decision
- HFBL
- AKTX
- Analyst Count
- HFBL 0
- AKTX 0
- Target Price
- HFBL N/A
- AKTX N/A
- AVG Volume (30 Days)
- HFBL 625.0
- AKTX 64.1K
- Earning Date
- HFBL 01-27-2025
- AKTX 02-15-2025
- Dividend Yield
- HFBL 4.06%
- AKTX N/A
- EPS Growth
- HFBL N/A
- AKTX N/A
- EPS
- HFBL 1.09
- AKTX N/A
- Revenue
- HFBL $19,727,000.00
- AKTX N/A
- Revenue This Year
- HFBL N/A
- AKTX N/A
- Revenue Next Year
- HFBL N/A
- AKTX N/A
- P/E Ratio
- HFBL $11.80
- AKTX N/A
- Revenue Growth
- HFBL N/A
- AKTX N/A
- 52 Week Low
- HFBL $10.60
- AKTX $0.90
- 52 Week High
- HFBL $14.60
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- HFBL 49.13
- AKTX 52.33
- Support Level
- HFBL $12.55
- AKTX $1.13
- Resistance Level
- HFBL $13.00
- AKTX $1.31
- Average True Range (ATR)
- HFBL 0.02
- AKTX 0.12
- MACD
- HFBL 0.00
- AKTX 0.03
- Stochastic Oscillator
- HFBL 28.72
- AKTX 60.87
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).